JP2024541315A - 中枢性低換気に関連する状態を治療するための方法および組成物 - Google Patents
中枢性低換気に関連する状態を治療するための方法および組成物 Download PDFInfo
- Publication number
- JP2024541315A JP2024541315A JP2024527312A JP2024527312A JP2024541315A JP 2024541315 A JP2024541315 A JP 2024541315A JP 2024527312 A JP2024527312 A JP 2024527312A JP 2024527312 A JP2024527312 A JP 2024527312A JP 2024541315 A JP2024541315 A JP 2024541315A
- Authority
- JP
- Japan
- Prior art keywords
- pharma
- acceptable salt
- nri
- pharmaceutical composition
- cai
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278324P | 2021-11-11 | 2021-11-11 | |
| US63/278,324 | 2021-11-11 | ||
| US202263305305P | 2022-02-01 | 2022-02-01 | |
| US63/305,305 | 2022-02-01 | ||
| PCT/US2022/049483 WO2023086433A1 (en) | 2021-11-11 | 2022-11-10 | Methods and compositions for treating conditions associated with central hypoventilation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024541315A true JP2024541315A (ja) | 2024-11-08 |
| JP2024541315A5 JP2024541315A5 (cg-RX-API-DMAC7.html) | 2025-11-17 |
Family
ID=84627454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527312A Pending JP2024541315A (ja) | 2021-11-11 | 2022-11-10 | 中枢性低換気に関連する状態を治療するための方法および組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250000823A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4429649A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024541315A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240108453A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022387440A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3237151A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL312688A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024005600A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023086433A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025207125A1 (en) * | 2024-03-26 | 2025-10-02 | The Regents Of The University Of California | Combination pharmacological interventions for obstructive sleep apnea |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| EP3685858A1 (en) * | 2019-01-24 | 2020-07-29 | Assistance Publique-Hopitaux De Paris | A noradrenergic system stimulator in the treatment of central hypoventilation syndromes |
| US20220362221A1 (en) * | 2019-11-04 | 2022-11-17 | Apnimed, Inc. (Delaware) | Combination pharmacological interventions for multiple mechanisms of obstructive sleep apnea |
-
2022
- 2022-11-10 MX MX2024005600A patent/MX2024005600A/es unknown
- 2022-11-10 US US18/709,055 patent/US20250000823A1/en active Pending
- 2022-11-10 KR KR1020247019140A patent/KR20240108453A/ko active Pending
- 2022-11-10 EP EP22830640.3A patent/EP4429649A1/en active Pending
- 2022-11-10 IL IL312688A patent/IL312688A/en unknown
- 2022-11-10 AU AU2022387440A patent/AU2022387440A1/en active Pending
- 2022-11-10 JP JP2024527312A patent/JP2024541315A/ja active Pending
- 2022-11-10 WO PCT/US2022/049483 patent/WO2023086433A1/en not_active Ceased
- 2022-11-10 CA CA3237151A patent/CA3237151A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250000823A1 (en) | 2025-01-02 |
| EP4429649A1 (en) | 2024-09-18 |
| WO2023086433A1 (en) | 2023-05-19 |
| MX2024005600A (es) | 2024-05-21 |
| KR20240108453A (ko) | 2024-07-09 |
| CA3237151A1 (en) | 2023-05-19 |
| AU2022387440A1 (en) | 2024-05-23 |
| IL312688A (en) | 2024-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6074003B2 (ja) | パーキンソン病の治療におけるオピオイド作動薬とオピオイド拮抗薬との組合せ | |
| JP5416085B2 (ja) | 下痢型および交替型過敏性腸症候群の処置のためのカッパ−オピエートアゴニスト | |
| US20220226288A1 (en) | Dexmedetomidine treatment regimens | |
| AU2016219650B2 (en) | Compositions and methods for extended therapy with aminopyridines | |
| US20110070319A1 (en) | Bifeprunox doses for treating schizophrenia | |
| US20230181583A1 (en) | Treating liver disorders with an ssao inhibitor | |
| TW200831097A (en) | Treatment of anxiety with eszopiclone | |
| CN117177741A (zh) | 用于治疗睡眠呼吸暂停的去甲肾上腺素再摄取抑制剂和大麻素的组合 | |
| KR20240108453A (ko) | 중추성 저환기와 관련된 질환을 치료하기 위한 방법 및 조성물 | |
| TW201828937A (zh) | 供治療重症肌無力及其他肌無力症候群之用途及組合物 | |
| CN117956959A (zh) | 用于治疗睡眠呼吸暂停的方法和组合物 | |
| CN118695856A (zh) | 用于治疗与中枢性通气不足相关的疾患的方法和组合物 | |
| CN117062626A (zh) | 用于治疗睡眠呼吸暂停的方法和组合物 | |
| JP2024523876A (ja) | 睡眠時無呼吸を治療するためのノルエピネフリン再取り込み阻害剤 | |
| JP2019528261A (ja) | ヒスタミン−3受容体インバースアゴニスト、アセチルコリンエステラーゼ阻害剤及びnmda受容体アンタゴニストの3種組合せ | |
| JP7556031B2 (ja) | 認知症患者の行動心理学的症状の治療 | |
| AU2024379175A1 (en) | Methods and compositions for treating sleep apnea with a combination of a glp-1 agonist and a second active agent | |
| JP5376481B1 (ja) | 経皮吸収用医薬組成物 | |
| IL230174A (en) | Pharmaceutical composition for the treatment of premature ejaculation | |
| US20240398771A1 (en) | Treatment of scleroderma and raynaud's syndrome | |
| WO2025162430A1 (zh) | 一种药物联用及其在预防或治疗神经退行性疾病中的用途 | |
| EA045669B1 (ru) | Способы лечения поведенческих и психологических симптомов у пациентов с деменцией | |
| HK40112834A (en) | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions | |
| WO2026025110A1 (en) | Treatment of refractory chronic cough | |
| WO2021146425A1 (en) | Methods of treating acute muscle spasms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251107 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251107 |